DHG Pharmaceutical JSC (DHG) — Cash Flow Reinvestment Rate
DHG Pharmaceutical JSC (DHG) has a Cash Flow Reinvestment Rate of 0.03x as of December 2025, reinvesting ₫14.65 Billion (capex ₫14.65 Billion ) from operating cash flow of ₫447.50 Billion. Explore DHG Pharmaceutical JSC capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
DHG Pharmaceutical JSC Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for DHG Pharmaceutical JSC across 7 annual periods. Also explore DHG Pharmaceutical JSC asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for DHG Pharmaceutical JSC (2019–2025)
Year-by-year capital reinvestment analysis for DHG Pharmaceutical JSC. For live market cap and broader valuation context, see DHG stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | ₫42.21 Billion | ₫1.22 Trillion | ₫42.21 Billion | ▼ -91.5% |
| 2024 | 0.41x | ₫534.66 Billion | ₫1.32 Trillion | ₫88.70 Billion | ▼ -88.1% |
| 2023 | 3.42x | ₫957.17 Billion | ₫279.88 Billion | ₫432.73 Billion | ▲ +1199.5% |
| 2022 | 0.26x | ₫237.20 Billion | ₫901.28 Billion | ₫233.99 Billion | ▲ +383.1% |
| 2021 | 0.05x | ₫24.65 Billion | ₫452.44 Billion | ₫24.56 Billion | ▼ -53.8% |
| 2020 | 0.12x | ₫97.43 Billion | ₫826.17 Billion | ₫88.81 Billion | ▲ +50.4% |
| 2019 | 0.08x | ₫65.73 Billion | ₫838.24 Billion | ₫57.10 Billion | — |